510(k) device
Bd Probetec Trichomonas Vaginalis (Tv) Qx Amplified Dna Assay
Becton, Dickinson & CO · Trichomonas Vaginalis Nucleic Acid Amplification Test System (OUY, Class II) · First FDA decision Aug 23, 2013, newest Aug 23, 2013HIV, hepatitis and sexually transmitted infections
Last checked: Nov 21, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "Bd Probetec"
MAUDE reports
27
Brand "Bd Probetec", since 2015
PubMed studies
75
Mentioning "Bd Probetec"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Bd Probetec Trichomonas Vaginalis (Tv) Qx Amplified Dna Assay
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K130268 · Decided Aug 23, 2013 · 200 days after receipt
Device type: Trichomonas Vaginalis Nucleic Acid Amplification Test System (OUY) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)Local determinationIn effectL38227First Coast Service Options, Inc.Updated Oct 20, 2023
- Gastrointestinal Pathogen (GIP) Panels Utilizing Multiplex Nucleic Acid Amplification Techniques (NAATs)Local determinationIn effectL38229Novitas Solutions, Inc.Updated Oct 20, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Bd Probetec", any status and sponsor, newest update first.
No registered device study names "Bd Probetec".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Bd Probetec", and for the whole product code for context.
This brand
27 reports: 26 malfunction, 1 injury, 0 death
Whole product code OUY
30 reports: 25 malfunction, 5 injury, 0 death
Newest reports for this brand
BECTON, DICKINSON & CO. (SPARKS)
1119779-2026-00256 · Received Feb 24, 2026 · Event dated Jan 21, 2026
Device type: Dna Probe, Nucleic Acid Amplification, Chlamydia (MKZ)
Device problem as coded: False Positive Result
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Bd Probetec"[tiab]. The summary above synthesizes these.
- Screening for Neisseria gonorrhoeae using the BD ProbeTec nucleic acid amplification test in a low prevalence genitourinary medicine clinic.
Killick V, Kell P, Plumb H, et al. · Int J STD AIDS · 2012Comparative Study
- Comparison of two automated methods for detection and differentiation of herpes simplex virus in clinical specimens.
Shabi Y, Jackson C, Sarty D, et al. · J Clin Virol · 2019Comparative Study
- Factors That Influence Confirmation of Neisseria gonorrhoeae Positivity by Molecular Methods.
Cuschieri K, Shepherd J, Graham C, et al. · J Clin Microbiol · 2019
- Clinical evaluation of the BD ProbeTecࡊ Chlamydia trachomatis Qx amplified DNA assay on the BD Viperࡊ system with XTRࡊ technology.
Taylor SN, Van Der Pol B, Lillis R, et al. · Sex Transm Dis · 2011Clinical Trial, Multicenter Study
- Evaluation of the BD ProbeTec ET system for direct detection of Mycobacterium bovis in veterinary specimens.
Bean DC, Hills A, Ryan T, et al. · J Clin Microbiol · 2007Research Support, Non-U.S. Gov't
- Preliminary study on rapid identification of Mycobacterium tuberculosis complex isolates by the BD ProbeTec ET system.
Wang SX, Sng LH, Tay L · J Med Microbiol · 2004Comparative Study
- Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae.
Golparian D, Boräng S, Sundqvist M, et al. · J Clin Microbiol · 2015Evaluation Study, Research Support, Non-U.S. Gov't
- Evaluation of the BD ProbeTec ET system for the direct detection of Mycobacterium tuberculosis from clinical samples.
Barber R · Br J Biomed Sci · 2008Comparative Study, Evaluation Study
- Performance of the BD ProbeTec ET direct detection assay for the analysis of Mycobacterium tuberculosis in respiratory and non-respiratory clinical specimens.
Somily AM, Habib HA, Sarwar MS, et al. · J Taibah Univ Med Sci · 2017
- Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.
Gaydos CA, Theodore M, Dalesio N, et al. · J Clin Microbiol · 2004Comparative Study, Research Support, Non-U.S. Gov't
- Homogeneous real-time detection of single-nucleotide polymorphisms by strand displacement amplification on the BD ProbeTec ET system.
Wang SS, Thornton K, Kuhn AM, et al. · Clin Chem · 2003
- Comparison of Culture, Real-Time DNA Amplification Assay and Ehrlich-Ziehl-Neelsen for Detection of Mycobacterium tuberculosis.
Karadağ A, Usta E, Bilgin K, et al. · Balkan Med J · 2013
Other devices of this type
Also filed under product code OUY.
- Xpert TVCepheid · 510(k) 2016
- Aptima Trichomonas Vaginalis Assay - PantherGen-Probe, Inc. · De Novo 2013
- Aptima Trichomonas vaginalis AssayHologic, Inc. · 510(k) 2023
- BD MAX CTGCTV2, BD MAX SystemBecton, Dickinson and Company · 510(k) 2019
- Bd Max Ct/Gc/Tv, Bd Max InstrumentBecton, Dickinson and Company · 510(k) 2016
- Solana Trichomonas AssayQuidel Corporation · 510(k) 2016
- AmpliVue Trichomonas AssayQuidel Corporation · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.